The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index.
Functions of Arginase Isoforms in Macrophage Inflammatory Responses: Impact on Cardiovascular Diseases and Metabolic Disorders
Open accessAbstract
Macrophages play a paramount role in immunity and inflammation-associated diseases, including infections, cardiovascular diseases, obesity-associated metabolic imbalances, and cancer. Compelling evidence from studies of recent years demonstrates that macrophages are heterogeneous and undergo heterogeneous phenotypic changes in response to microenvironmental stimuli. The M1 killer type response and the M2 repair type response are best known, and are two extreme examples. Among other markers, inducible nitric oxide synthase and type-I arginase (Arg-I), the enzymes that are involved in l-arginine/nitric oxide (NO) metabolism, are associated with the M1 and M2 phenotype, respectively, and therefore widely used as the markers for characterization of the two macrophage phenotypes. There is also a type-II arginase (Arg-II), which is expressed in macrophages and prevalently viewed as having the same function as Arg-I in the cells. In contrast to Arg-I, little information on the role of Arg-II in macrophage inflammatory responses is available. Emerging evidence, however, suggests that differential roles of Arg-I and Arg-II in regulating macrophage functions. In this article, we will review recent developments on the functional roles of the two arginase isoforms in regulation of macrophage inflammatory responses by focusing on their impact on the pathogenesis of cardiovascular diseases and metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ARG1 in myeloid cells mainly functions as an enzyme to hydrolyze arginine to produce ornithine as part of the urea cycle, which both promotes tissue repair through generation of polyamines and collagens, and also reduces nitric oxide production from inducible nitric oxide synthase through decreasing intracellular arginine availability (76–78).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“, macrophage plasticity, in response to specific signals as a consequence of adaptation to local tissue environmental cues (6, 7).”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 3×
“, macrophage plasticity, in response to specific signals as a consequence of adaptation to local tissue environmental cues (6, 7).”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · cited 1×
“Later on, it was characterized that M1 macrophages are more easily activated by LPS to produce cytotoxic NO via iNOS, whereas M2 macrophages generate little NO but more ornithine from the same substrate l-arginine via arginase (15).”
BackgroundAlternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183 · cited 1×
“NO production from iNOS in M1 macrophages inhibits cell proliferation and kills pathogens, a M1 killing type response (16, 17), while ornithine production promotes cell proliferation and repairs tissue damage through generation of polyamines and collagen in M2 macrophages, a M2 repairing type response (11, 18).”
BackgroundMonocytes and macrophages: developmental pathways and tissue homeostasis
Ginhoux, F., & Jung, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3671 · Cited by 1,840
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,480
Jenkins, S. J., Rückerl, D., Cook, P. C., Jackson-Jones, L. H., Finkelman, F. D., van Rooijen, N., MacDonald, A. S., & Allen, J. E. (2011) · Science · doi:10.1126/science.1204351 · Cited by 1,404 · cited 1×
“Moreover, tissue macrophages are not terminally differentiated and are maintained throughout life by local proliferative selfrenewal (4,5).”
BackgroundŚwirski, F. K., Libby, P., Aïkawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,308
Emerging regulation and functions of autophagy
Boya, P., Reggiori, F., & Codogno, P. (2013) · Nature Cell Biology · doi:10.1038/ncb2788 · Cited by 1,216 · cited 1×
“Moreover, we also show that Arg-II negatively regulates autophagy function – a cell protective mechanism of lysosomal proteolysis aiming to remove harmful proteins (79) – in endothelial cells, which is also independent on its l-arginine–urea hydrolase activity [Ref.”
BackgroundM1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. D. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,169
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041 · cited 1×
“Moreover, tissue macrophages are not terminally differentiated and are maintained throughout life by local proliferative selfrenewal (4,5).”
BackgroundHibbs, J. B., Vavrin, Z., & Taintor, R. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.2.550 · Cited by 938 · cited 1×
“NO production from iNOS in M1 macrophages inhibits cell proliferation and kills pathogens, a M1 killing type response (16, 17), while ornithine production promotes cell proliferation and repairs tissue damage through generation of polyamines and collagen in M2 macrophages, a M2 repairing type response (11, 18).”
BackgroundArginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000371 · Cited by 816 · cited 1×
“However, mice with specific Arg-I gene deficiency in macrophages show exacerbated Th2 response and fibrosis in the liver of Schistosoma mansoni infected mice (65), which does not seem to support previous suggestions in promotion of Th2 responses (63).”
BackgroundAblation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804
Hoeffel, G., Wang, Y., Greter, M., See, P., Teo, P., Malleret, B., Leboeuf, M., Low, D., Oller, G., Almeida, F., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120340 · Cited by 786
R EGULATION OF E NZYMES OF THE U REA C YCLE AND A RGININE M ETABOLISM
Morris, S. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.110801.140547 · Cited by 736 · cited 1×
“2 mmol/L) far exceed the Km of eNOS (2– 20 μmol/L) (67).”
BackgroundHesse, M., Modolell, M., Flamme, A. C. L., Schito, M. L., Fuentes, J. M., Cheever, A. W., Pearce, E. J., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6533 · Cited by 723
Xia, Y., Dawson, V. L., Dawson, T. M., Snyder, S. H., & Zweier, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6770 · Cited by 717 · cited 1×
“The best characterization of Arg-II function is done in vascular endothelial cells in which the isoenzyme, similar to Arg-I, metabolizes l-arginine to urea and lornithine, which limits l-arginine bioavailability for generation of the vasoprotective NO via eNOS, resulting in vascular endothelial dysfunction (33, 34).”
BackgroundArginine Metabolism: Boundaries of Our Knowledge
Morris, S. M. (2007) · Journal of Nutrition · doi:10.1093/jn/137.6.1602s · Cited by 649
Munder, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5347 · Cited by 647
El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M.-S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1671 · Cited by 646
Wentworth, J. M., Naselli, G., Brown, W. A., Doyle, L., Phipson, B., Smyth, G. K., Wabitsch, M., O’Brien, P. E., & Harrison, L. C. (2010) · Diabetes · doi:10.2337/db09-0287 · Cited by 636
Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.
Munder, M., Eichmann, K., Morán, J., Centeno, F., Soler, G., & Modolell, M. (1999) · Journal of Immunology · doi:10.4049/jimmunol.163.7.3771 · Cited by 619
Comparative properties of arginases
Jenkinson, C. P., Grody, W. W., & Cederbaum, S. D. (1996) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/0305-0491(95)02138-8 · Cited by 610 · cited 2×
“Although both Arg-I and ArgII are to hydrolyze l-arginine to produce urea and l-ornithine (25), the functional impact of the two isoenzymes is either similar or different depending on specific organs/cells.”
BackgroundMacrophage plasticity in experimental atherosclerosis
Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.-T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008852 · Cited by 517 · cited 2×
“The expression of Arg-I and Arg-II is inducible in macrophages depending on external stimuli (42, 43).”
BackgroundResultM1 and M2 Macrophages: The Chicken and the Egg of Immunity
Mills, C. D., & Ley, K. F. (2014) · Journal of Innate Immunity · doi:10.1159/000364945 · Cited by 422 · cited 1×
“In contrast, M2 macrophages produce more anti-inflammatory cytokines and substances involved in repairing function, typically, arginase/ornithine, EGF, VEGF, and TGF-β, and mannose receptor (9).”
BackgroundLi, H. Z., Meininger, C. J., Hawker, J. R., Haynes, T. E., Kepka‐Lenhart, D., Mistry, S. K., Morris, S. M., & Wu, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e75 · Cited by 395 · cited 1×
“While the cell proliferation– stimulating effect of Arg-II is dependent on its l-arginine–urea hydrolase activity via synthesis of ornithine and polyamines (71, 78), the cell apoptosis/senescence-promoting effect is independent of its enzymatic activity (Figure 3).”
BackgroundDiabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity
Romero, M. J., Platt, D. H., Tawfik, H. E., Labazi, M., El‐Remessy, A. B., Bartoli, M., Caldwell, R. B., & Caldwell, R. W. (2007) · Circulation Research · doi:10.1161/circresaha.107.155028 · Cited by 386 · cited 1×
“expression in porcine coronary arterioles in response to hydrogen peroxide (H2O2) and peroxynitrite (92) and Arg-II (but not Arg-I) expression and/or activity in women with preeclampsia (93) and in human endothelial cells in response to thrombin (35), oxidized LDL (94), and hyperglycemia (36).”
BackgroundCutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production
Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., & Murray, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2173 · Cited by 331
Kropf, P., Fuentes, J. M., Fähnrich, E., Arpa, L., Herath, S., Weber, V., Soler, G., Celada, A., Modolell, M., & Müller, I. (2005) · The FASEB Journal · doi:10.1096/fj.04-3416fje · Cited by 295
Translational evidence that impaired autophagy contributes to arterial ageing
LaRocca, T. J., Henson, G. D., Thorburn, A. M., Sindler, A. L., Pierce, G. L., & Seals, D. R. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.229690 · Cited by 258
Antoniades, C. A., Shirodaria, C. C., Leeson, P., Antonopoulos, A. S., Warrick, N., Van-Assche, T., Cunnington, C., Tousoulis, D., Pillai, R. G., Ratnatunga, C., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp061 · Cited by 258
Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression
Pauleau, A., Rutschman, R., Lang, R., Pernis, A. B., Watowich, S. S., & Murray, P. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7565 · Cited by 247 · cited 2×
“, by Th2 cytokines IL-4 and IL-13 (44, 61, 62).”
Kim, J. H., Bugaj, L. J., Oh, Y. J., Bivalacqua, T. J., Ryoo, S., Soucy, K. G., Santhanam, L., Webb, A. K., Camara, A., Sikka, G., et al. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91393.2008 · Cited by 244 · cited 1×
“The best characterization of Arg-II function is done in vascular endothelial cells in which the isoenzyme, similar to Arg-I, metabolizes l-arginine to urea and lornithine, which limits l-arginine bioavailability for generation of the vasoprotective NO via eNOS, resulting in vascular endothelial dysfunction (33, 34).”
Backgroundl -Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm
Wilson, A. M., Harada, R., Nair, N., Balasubramanian, N., & Cooke, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.683656 · Cited by 241
Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway
Ming, X., Barandiér, C., Viswambharan, H., Kwak, B. R., Mach, F., Mazzolai, L., Hayoz, D., Ruffieux, J., Rusconi, S., Montani, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142867.26182.32 · Cited by 240
Gotoh, T., Sonoki, T., Nagasaki, A., Terada, K., Takiguchi, M., & Mori, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01015-0 · Cited by 236 · cited 2×
“Unlike Arg-I, Arg-II is confined mainly to kidney, brain, prostate, intestine, and also pancreas (22, 23, 32).”
BackgroundLiu, C., Lǐ, Y., Yu, J., Ling, F., Hou, S., Liu, Y., Guo, M., Xie, Y., Meng, J., Zhang, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054841 · Cited by 233 · cited 1×
“In macrophages, however, ROCK kinase inhibitor enhances Arg-I expression and shift M1 to M2 phenotype (95), suggesting that ROCK pathway may inhibit Arg-I expression.”
BackgroundHuman type II arginase: sequence analysis and tissue-specific expression
Morris, S. M., Bhamidipati, D., & Kepka‐Lenhart, D. (1997) · Gene · doi:10.1016/s0378-1119(97)00099-1 · Cited by 216
Macrophage arginine metabolism and the inhibition or stimulation of cancer
Mills, C. D., Shearer, J. D., Evans, R. L., & Caldwell, M. D. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2709 · Cited by 191 · cited 1×
“In particular, monocytes and macrophages are recruited into tumors and regulate tumor growth by changing their functional phenotypes, which is originally demonstrated by Mills and colleagues (100).”
BackgroundGray, M. J., Poljakovic, M., Kepka-Lenhart, D., & Morris, S. M. (2005) · Gene · doi:10.1016/j.gene.2005.04.004 · Cited by 191 · cited 2×
“, by Th2 cytokines IL-4 and IL-13 (44, 61, 62).”
Cloning and Characterization of the Human Type II Arginase Gene
Vockley, J. G., Jenkinson, C. P., Shukla, H., Kern, R. M., Grody, W. W., & Cederbaum, S. D. (1996) · Genomics · doi:10.1006/geno.1996.0606 · Cited by 191 · cited 2×
“Unlike Arg-I, Arg-II is confined mainly to kidney, brain, prostate, intestine, and also pancreas (22, 23, 32).”
BackgroundSchrijvers, D. M., Meyer, G. R. Y. D., & Martinet, W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224899 · Cited by 189
Santhanam, L., Lim, H. K., Lim, H. K., Miriel, V. A., Brown, T. R., Patel, M. D., Balanson, S., Ryoo, S., Anderson, M., Irani, K., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.157727 · Cited by 188 · cited 1×
“For example, increased activity and/or expression of either Arg-I or Arg-II in endothelial cells impair the vasoprotective endothelial NO production via eNOS (27).”
BackgroundShemyakin, A. S., Kövamees, O., Rafnsson, A. T., Böhm, F., Svenarud, P. K., Settergren, M., Jung, C., & Pernow, J. (2012) · Circulation · doi:10.1161/circulationaha.112.140335 · Cited by 185
Mouse Model for Human Arginase Deficiency
Iyer, R. K., Yoo, P. K., Kern, R. M., Rozengurt, N., Tsoa, R. W., O’Brien, W. E., Yu, H., Grody, W. W., & Cederbaum, S. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4491-4498.2002 · Cited by 171 · cited 2×
“The vital effect of hepatic Arg-I is evidenced by the studies showing that Arg-I knockout mice reveal severe symptoms of hyperammonemia and die between postnatal days 10 and 14 (31).”
BackgroundSanthanam, L., Christianson, D. W., Nyhan, D. P., & Berkowitz, D. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90627.2008 · Cited by 166 · cited 1×
“Another alternative hypothesis is that a specific intracellular pool of l-arginine for NO production may exist in endothelial cells and could be depleted by enhanced arginase (73), yet, it is highly speculative.”
BackgroundRajapakse, A. G., Yepuri, G., Carvas, J. M., Stein, S., Matter, C. M., Scerri, I., Ruffieux, J., Montani, J., Ming, X., & Yang, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019237 · Cited by 164
Ming, X., Rajapakse, A. G., Yepuri, G., Xiong, Y., Carvas, J. M., Ruffieux, J., Scerri, I., Wu, Z., Popp, K., Li, J., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000992 · Cited by 155 · cited 9×
“Arg-II−/−mice, when fed a HFD, although have similar body weight as WT controls, reveal lower fasting plasma glucose concentration, are more glucose tolerant and insulin sensitive (43) as compared to WT mice on HFD.”
BackgroundMethodInfluentialden Bossche, J. V., Lamers, W. H., Köhler, E. S., Geuns, J. M. C., Alhonen, L. I., Uimari, A., Pirnes-Karhu, S., Overmeire, E. V., Morias, Y., Brys, L., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911453 · Cited by 145
Molecular cloning and nucleotide sequence of cDNA for human liver arginase.
Haraguchi, Y., Takiguchi, M., Amaya, Y., Kawamoto, S., Matsuda, I., & Mori, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.412 · Cited by 143 · cited 1×
“The primary function of Arg-I is to remove excessive nitrogen produced from amino acid metabolism through hepatic urea cycle, which is otherwise toxic for our body (28, 29), because Arg-I is constitutively and abundantly expressed as a cytosolic enzyme in the liver (30).”
BackgroundHyperargininemia due to liver arginase deficiency
Crombez, E. A., & Cederbaum, S. D. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.11.004 · Cited by 135 · cited 2×
“Patients with Arg-I deficiency due to gene mutation reveal urea cycle disorder, hyperargininemia, and exhibit progressive neurologic impairment, development retardation, and hepatic dysfunction associated with cirrhosis and carcinoma in early childhood (28, 29).”
BackgroundArginase: The Emerging Therapeutic Target for Vascular Oxidative Stress and Inflammation
Yang, Z., & Ming, X. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00149 · Cited by 133
Positive crosstalk between arginase‐II and S6K1 in vascular endothelial inflammation and aging
Yepuri, G., Velagapudi, S., Xiong, Y., Rajapakse, A. G., Montani, J., Ming, X., & Yang, Z. (2012) · Aging Cell · doi:10.1111/acel.12001 · Cited by 129 · cited 8×
“Interestingly, silencing Arg-II gene in senescent endothelial cells or deficiency in Arg-II gene in mice reduces S6K1 activity, recouples eNOS function in aging, and inhibits endothelial expression of adhesion molecules such as ICAM-1 and VCAM-1, resulting in inhibition of monocyte-endothelial cell interaction, demons…”
BackgroundInfluentialRyoo, S., Bhunia, A. K., Chang, F., Shoukas, A. A., Berkowitz, D. E., & Romer, L. H. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.044 · Cited by 127 · cited 3×
“Silencing Arg-II gene in human monocyte/macrophage cell lines decreases the cell adhesion to endothelial cells with reduced production of pro-inflammatory cytokines in response to LPS or ox-LDL at both the mRNA and protein levels.”
BackgroundHolowatz, L. A., & Kenney, W. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.128959 · Cited by 117
Insulin and the arginine paradox.
Kurz, S. D., & Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119166 · Cited by 112 · cited 1×
“Even though, acute l-arginine supplementation in cells, isolated blood vessels, or in animals or in patients is able to enhance NO production and improve endothelium-dependent relaxations, a situation called “arginine paradox” (68, 69).”
BackgroundSankaralingam, S., Xu, H., & Davidge, S. T. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp277 · Cited by 105 · cited 1×
“expression in porcine coronary arterioles in response to hydrogen peroxide (H2O2) and peroxynitrite (92) and Arg-II (but not Arg-I) expression and/or activity in women with preeclampsia (93) and in human endothelial cells in response to thrombin (35), oxidized LDL (94), and hyperglycemia (36).”
BackgroundYoram Vodovotz, B. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0105 · Cited by 104
The Arginase II Gene Is an Anti-inflammatory Target of Liver X Receptor in Macrophages
Marathe, C., Bradley, M. N., Hong, C., López, F., de Galarreta, C. M. R., Tontonoz, P., & Castrillo, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605237200 · Cited by 102 · cited 1×
“An early study showed that Arg-II gene is a direct target of liver X receptor that has been shown to exert inhibitory effects on expression of inflammatory genes in macrophages (49).”
BackgroundArginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages?
Kepka‐Lenhart, D., Mistry, S. K., Wu, G., & Morris, S. M. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.6.r2237 · Cited by 99
To Give or Not to Give? Lessons from the Arginine Paradox
Dioguardi, F. S. (2011) · Lifestyle Genomics · doi:10.1159/000327777 · Cited by 95 · cited 1×
“These studies do not support a role of absolute l-arginine deficiency caused by arginase, but strongly implicate that too much l-arginine is even harmful, which is probably due to production of other undesired metabolites from l-arginine as speculated (76).”
BackgroundThengchaisri, N., Hein, T. W., Wang, W., Xu, X. Y., Li, Z., Fossum, T. W., & Kuo, L. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000233334.24805.62 · Cited by 94
Xiong, Y., Yu, Y., Montani, J., Yang, Z., & Ming, X. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000096 · Cited by 91
Chromosomal Localization of the Human Arginase II Gene and Tissue Distribution of Its mRNA
Gotoh, T., Araki, M., & Mori, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6473 · Cited by 90
Chen, B., Calvert, A. E., Cui, H., & Nelin, L. D. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00183.2009 · Cited by 88 · cited 1×
“While the cell proliferation– stimulating effect of Arg-II is dependent on its l-arginine–urea hydrolase activity via synthesis of ornithine and polyamines (71, 78), the cell apoptosis/senescence-promoting effect is independent of its enzymatic activity (Figure 3).”
BackgroundOuimet, M. I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.007 · Cited by 86
Dizikes, G. J., Grody, W. W., Kern, R. M., & Cederbaum, S. D. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80333-3 · Cited by 83
Transcriptional regulation of macrophage arginase 1 expression and its role in atherosclerosis
Pourcet, B., & Pineda‐Torra, I. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.10.003 · Cited by 82 · cited 1×
“The complexity of Arg-I gene regulation mechanisms are further complicated by the fact that these transcription factors can be regulated by post-translational modification mechanisms such as SUMOylation and ubiquitination that are participating in the regulation of Arg-1 gene [for detailed description of these mechani…”
BackgroundRegulation of Arginine Availability and Its Impact on NO Synthesis
Morris, S. M. (2000) · Elsevier eBooks · doi:10.1016/b978-012370420-7/50012-5 · Cited by 75
The gene for human liver arginase (ARG1) is assigned to chromosome band 6q23.
Sparkes, R. S., Dizikes, G. J., Klisak, I. J., Grody, W. W., Mohandas, T. K., Heinzmann, C., Zollman, S., Lusis, A. J., & Cederbaum, S. D. (1986) · PubMed · Cited by 72
Stanhewicz, A. E., Bruning, R. S., Smith, C. J. W., Kenney, W. L., & Holowatz, L. A. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01257.2011 · Cited by 70
Immunohistochemical study of arginase 1 and 2 in various tissues of rats
Choi, S., Park, C., Ahn, M., Lee, J. H., & Shin, T. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.09.002 · Cited by 70 · cited 2×
“Arg-I has been reported to be expressed also in many extrahepatic tissues such as stomach, pancreas, and lung (32).”
BackgroundZitvogel, L., & Tursz, T. (2005) · Nature Biotechnology · doi:10.1038/nbt1105-1372 · Cited by 65 · cited 1×
“This phenotypic cell is mainly participating in resolution of inflammation, tissue repairing, angiogenesis, allergy, and tumor progression (10).”
BackgroundAge-Related Alteration of Arginase Activity Impacts on Severity of Leishmaniasis
Müller, I., Hailu, A., Choi, B., Abebe, T., Fuentes, J. M., Munder, M., Modolell, M., & Kropf, P. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000235 · Cited by 60
Shin, W., Berkowitz, D. E., & Ryoo, S.-W. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.10.068 · Cited by 57
Stempin, C. C., Tanos, T., Coso, O. A., & Cerbán, F. M. (2003) · European Journal of Immunology · doi:10.1002/eji.200324313 · Cited by 57 · cited 1×
“The stress sensor p38mapk has been demonstrated to participate in up-regulation of activity and expression of Arg-I and Arg-II in macrophages (85, 86).”
Backgroundp38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-Uncoupling in Obesity
Yu, Y., Rajapakse, A. G., Montani, J., Yang, Z., & Ming, X. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0113-z · Cited by 56 · cited 2×
“Our most recent study provides evidence showing that p38mapk also functions as downstream effector of Arg-II in endothelial cells, causing oxidative stress through eNOS-uncoupling, since overexpression of Arg-II in human endothelial cells causes eNOS-uncoupling and augments p38mapk activation (90), and inhibition of p…”
BackgroundToque, H. A., Romero, M. J., Tostes, R. C., Shatanawi, A., Chandra, S., Carneiro, Z. N., Inscho, E. W., Webb, R. C., Caldwell, R. B., & Caldwell, R. W. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01996.x · Cited by 52
Gibbings, S. L., Elkins, N. D., Fitzgerald, H., Tiao, J., Weyman, M. E., Shibao, G. N., Fini, M. A., & Wright, R. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150847 · Cited by 52 · cited 1×
“The complexity of Arg-I gene regulation mechanisms are further complicated by the fact that these transcription factors can be regulated by post-translational modification mechanisms such as SUMOylation and ubiquitination that are participating in the regulation of Arg-1 gene [for detailed description of these mechani…”
BackgroundWang, X., Chen, Y., Qin, W., Zhang, W., Wei, S., Wang, J., Liu, F. Q., Gong, L., An, F. S., Zhang, Y., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.229302 · Cited by 52 · cited 1×
“A study in human smooth muscle cells showing that overexpression of Arg-I gene is able to decrease LPS-induced pro-inflammatory cytokine production (64), seems to support the”
BackgroundDizikes, G. J., Spector, E., & Cederbaum, S. D. (1986) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01570732 · Cited by 47
Dileepan, K. N., PAGE, J. C., Li, Y., & Stechschulte, D. J. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.387 · Cited by 46 · cited 1×
“L-ARGININE METABOLISM, iNOS, AND ARGINASE IN MACROPHAGE FUNCTIONAL POLARIZATION The suggestion that l-arginine metabolism could be involved in regulation of macrophage phenotypes was from early studies with macrophages isolated from the Th1 strain mouse C57B1/6 and Th2 strain BALB/c mouse (13, 14).”
BackgroundParadoxical effect of l-arginine: Acceleration of endothelial cell senescence
Scalera, F., Closs, E. I., Flick, E., Martens‐Lobenhoffer, J., Boissel, J., Lendeckel, U., Heimburg, A., & Bode‐Böger, S. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.091 · Cited by 45
Xiong, Y., Forbiteh, M., Yu, Y., Montani, J., Ming, X., & Yang, Z. (2014) · Aging · doi:10.18632/aging.100663 · Cited by 45 · cited 4×
“Even though, acute l-arginine supplementation in cells, isolated blood vessels, or in animals or in patients is able to enhance NO production and improve endothelium-dependent relaxations, a situation called “arginine paradox” (68, 69).”
BackgroundInfluentialPurification of rat kidney arginases A1 and A4 and their subcellular distribution.
Skrzypek-Osiecka, I., Robin, Y., & Porembska, Z. (1983) · PubMed · Cited by 44
Low response of BALB/c macrophages to priming and activating signals
Oswald, I. P., Afroun, S., Bray, D. H., Petit, J. F., & Lemaire, G. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.52.3.315 · Cited by 44 · cited 1×
“L-ARGININE METABOLISM, iNOS, AND ARGINASE IN MACROPHAGE FUNCTIONAL POLARIZATION The suggestion that l-arginine metabolism could be involved in regulation of macrophage phenotypes was from early studies with macrophages isolated from the Th1 strain mouse C57B1/6 and Th2 strain BALB/c mouse (13, 14).”
BackgroundThrombin induces endothelial arginase through AP-1 activation
Zhu, W., Chandrasekharan, U. M., Bandyopadhyay, S., Morris, S. M., DiCorleto, P. E., & Kashyap, V. S. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00466.2009 · Cited by 37 · cited 1×
“This seems to be also the case in bovine and rat aortic endothelial cells for Arg-I expression (87) and in human endothelial cells and mouse penile tissues for Arg-II (88, 89).”
BackgroundProtein Tyrosine Phosphatase SHP2 Mediates Chronic Insulin-Induced Endothelial Inflammation
Giri, H., Muthuramu, I., Dhar, M., Rathnakumar, K., Ram, U., & Dixit, M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.239251 · Cited by 37 · cited 1×
“This seems to be also the case in bovine and rat aortic endothelial cells for Arg-I expression (87) and in human endothelial cells and mouse penile tissues for Arg-II (88, 89).”
BackgroundVaisman, B. L., Andrews, K. L., Khong, S. M. L., Wood, K. C., Moore, X. L., Fu, Y., Kepka‐Lenhart, D., Morris, S. M., Remaley, A. T., & Chin-Dusting, J. P. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039487 · Cited by 35 · cited 1×
“Arg-II as therapeutic target in chronic inflammatory disorders such as age-associated vascular dysfunctions, atherosclerosis, and type-II diabetes and complications has shown promising beneficial effects in genetic modified mouse models (39, 43, 96).”
BackgroundArginase Deficiency With New Phenotype and a Novel Mutation: Contemporary Summary
Tsang, J. P. K., Poon, W. L., Luk, H., Fung, C. W., Ching, C. K., Mak, C. M., Lam, C. W., Siu, T. S., Tam, S., & Wong, V. C. N. (2012) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.06.012 · Cited by 35
Exogenous Nitric Oxide Inhibits VCAM-1 Expression in Human Peritoneal Mesothelial Cells
Lee, S. K., Kim, J. H., Yang, W. S., Kim, S. B., Park, S.-K., & Park, J. S. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000054733 · Cited by 33
Liscovsky, M. V., Ranocchia, R. P., Gorlino, C. V., Alignani, D., Morón, G., Maletto, B. A., & Pistoresi-Palencia, M. C. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02938.x · Cited by 29 · cited 1×
“The stress sensor p38mapk has been demonstrated to participate in up-regulation of activity and expression of Arg-I and Arg-II in macrophages (85, 86).”
BackgroundPekarová, M., Lojek, A., Martiskova, H., Vašíček, O., Binó, L., Klinke, A., Lau, D., Kuchta, R., Kadlec, J., Vrba, R., et al. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/321979 · Cited by 28
Fliggeri, J., Jungi, T. W., & Blum, J. W. (1999) · Immunobiology · doi:10.1016/s0171-2985(99)80068-0 · Cited by 23
Starey, C. J. H. (1966) · BMJ · doi:10.1136/bmj.2.5514.646-f · Cited by 14
Flagged first, then by citations
3 of the 107 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Arginase: A Multifaceted Enzyme Important in Health and Disease
Caldwell, R. W., Rodriguez, P. C., Toque, H. A., Narayanan, S. P., & Caldwell, R. B. (2018) · Physiological Reviews · doi:10.1152/physrev.00037.2016 · Cited by 495
“For instance, arginase-induced increases in polyamines and proline production can lead to thickening, fibrosis, and stiffening of blood vessels and airways, hypertrophy and fibrosis of the heart and kidneys, neurodegeneration, and growth of tumors (51, 127, 164, 238).”
BackgroundArginase: an old enzyme with new tricks
Caldwell, R. B., Toque, H. A., Narayanan, S. P., & Caldwell, R. W. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.006 · Cited by 358
Arginine and Endothelial Function
Gambardella, J., Khondkar, W., Morelli, M. B., Wang, X., Santulli, G., & Trimarco, V. (2020) · Biomedicines · doi:10.3390/biomedicines8080277 · Cited by 266
The PI3K/Akt Pathway in Meta-Inflammation
Acosta‐Martínez, M., & Cabail, M. Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315330 · Cited by 259
“Arginase 1 is one of the hallmarks of alternatively activated macrophages and contributes to the resolution of inflammation and tissue repair by degrading arginine and preventing the generation of cytotoxic nitric oxide [79].”
BackgroundToledo, B., Chen, L. Z., Paniagua-Sancho, M., Marchal, J. A., Perán, M., & Giovannetti, E. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01559-0 · Cited by 255
Metadata
- Authors
- Yang, Z., & Ming, X.-F.
- Affiliations
- University of Fribourg (CH)
- Corresponding author
- Yang, Zhihong
- Ming, Xiu-Fen
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014-10-27
- Volume
- 5
- Pages
- 533-533
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC4209887
- OpenAlex
- W2018261122
- Cited by
- 290
- References
- 107
- Citations by year
- 2026: 20 · 2025: 31 · 2024: 32 · 2023: 39 · 2022: 30 · 2021: 29 · 2020: 40 · 2019: 23 · 2018: 15 · 2017: 16 · 2016: 5 · 2015: 10
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Foundation (120435, 310030)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310000-120435/1, 141070, 120435, 310000, 310030)
- Schweizerische Herzstiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- macrophage polarization, M1/M2 macrophage phenotype, inducible nitric oxide synthase, macrophage inflammation, cardiovascular disease, metabolic disorders, obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review